The Crisis of Access to Early Diagnosis of Autism and Emerging Solutions

This webinar will focus on studies validating social visual engagement--the moment-by-moment way children look at and learn about their social surroundings--as a quantitative biomarker for autism. Leveraging this science, Dr. Klin and colleagues have developed and validated an eye-tracking-based tool for the diagnosis and assessment of autism in toddlers aged 16-30 months. Called EarliPoint, it is an objective, standardized, quantitative, and cost-effective tool for the early diagnosis and assessment of autism. Clinical validation data has led to its FDA clearance for broad use in the community. Dr. Klin will explain why it has potential for making the diagnosis process more efficient and accessible.

Watch webinar recording:

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

View past webinar recordings.

Presentation

Download Slide Presentation

Presented by

Ami Klin, Ph.D.

Director, Marcus Autism Center at Children's Healthcare of Atlanta

Georgia Research Alliance Eminent Scholar

Professor & Chief, Division of Autism & Related Disabilities, Department of Pediatrics

Emory University School of Medicine & Emory Center for Translational Social Neuroscience

2018 Ruane Prizewinner for Outstanding Achievement in Child & Adolescent Psychiatric Research

Dr. Ami Klin, Director of the Marcus Autism Center in Atlanta, has co-developed a technology that is enabling his team to diagnose autism spectrum disorder much earlier than ever. By carefully tracking the eye movements of infants, he has shown that the biology of newborns begins to diverge after only 2 months in ways that mark the very beginnings of the disorder. His team trains parents to work with their children from a very early age to minimize the impact of ASD.

Advice for Parents Concerned About Autism

Moderated by

Read Full Bio

Jeffrey Borenstein, M.D.

Brain & Behavior Research Foundation

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.

The Crisis of Access to Early Diagnosis of Autism and Emerging Solutions

Presentation

Ami Klin, Ph.D.

Jeffrey Borenstein, M.D.

ABOUT US

CONTACT US